249 related articles for article (PubMed ID: 22376143)
1. Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa.
Miot J; Wagner M; Khoury H; Rindress D; Goetghebeur MM
Cost Eff Resour Alloc; 2012 Feb; 10(1):2. PubMed ID: 22376143
[TBL] [Abstract][Full Text] [Related]
2. Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.
Tony M; Wagner M; Khoury H; Rindress D; Papastavros T; Oh P; Goetghebeur MM
BMC Health Serv Res; 2011 Nov; 11():329. PubMed ID: 22129247
[TBL] [Abstract][Full Text] [Related]
3. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
[TBL] [Abstract][Full Text] [Related]
4. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
[TBL] [Abstract][Full Text] [Related]
5. Impact on decision making framework for medicine purchasing in Chinese public hospital decision-making: determining the value of five dipeptidyl peptidase 4 (DPP-4) inhibitors.
Bao Y; Gao B; Meng M; Ge B; Yang Y; Ding C; Shi B; Tian L
BMC Health Serv Res; 2021 Aug; 21(1):807. PubMed ID: 34384428
[TBL] [Abstract][Full Text] [Related]
6. Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decision-making framework to growth hormone for Turner syndrome patients.
Goetghebeur MM; Wagner M; Khoury H; Rindress D; Grégoire JP; Deal C
Cost Eff Resour Alloc; 2010 Apr; 8():4. PubMed ID: 20377888
[TBL] [Abstract][Full Text] [Related]
7. Exploring the perspectives and preferences for HTA across German healthcare stakeholders using a multi-criteria assessment of a pulmonary heart sensor as a case study.
Wahlster P; Goetghebeur M; Schaller S; Kriza C; Kolominsky-Rabas P;
Health Res Policy Syst; 2015 Apr; 13():24. PubMed ID: 25928535
[TBL] [Abstract][Full Text] [Related]
8. Multiple Criteria Decision Analysis (MCDA) for evaluating cancer treatments in hospital-based health technology assessment: The Paraconsistent Value Framework.
Campolina AG; Estevez-Diz MDP; Abe JM; de Soárez PC
PLoS One; 2022; 17(5):e0268584. PubMed ID: 35613115
[TBL] [Abstract][Full Text] [Related]
9. Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA.
Wagner M; Khoury H; Bennetts L; Berto P; Ehreth J; Badia X; Goetghebeur M
BMC Cancer; 2017 Apr; 17(1):272. PubMed ID: 28412971
[TBL] [Abstract][Full Text] [Related]
10. TESTING MULTI-CRITERIA DECISION ANALYSIS FOR MORE TRANSPARENT RESOURCE-ALLOCATION DECISION MAKING IN COLOMBIA.
Castro Jaramillo HE; Goetghebeur M; Moreno-Mattar O
Int J Technol Assess Health Care; 2016 Jan; 32(4):307-314. PubMed ID: 27691990
[TBL] [Abstract][Full Text] [Related]
11. Pragmatic Multicriteria Decision Analysis (MCDA) Combined With Advanced Pharmacoepidemiology for Benefit-Risk Assessments of Medicines Adapted to the Real-Life Constraints of Regulators: Development and Case Study.
Goetghebeur MM; Wagner M; Nikodem M; Zyla A; Micaleff A; Amzal B
Ther Innov Regul Sci; 2016 Sep; 50(5):620-631. PubMed ID: 30231761
[TBL] [Abstract][Full Text] [Related]
12. Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut).
Guarga L; Badia X; Obach M; Fontanet M; Prat A; Vallano A; Torrent J; Pontes C
Orphanet J Rare Dis; 2019 Jun; 14(1):157. PubMed ID: 31248421
[TBL] [Abstract][Full Text] [Related]
13. DRUG EVALUATION AND DECISION MAKING IN CATALONIA: DEVELOPMENT AND VALIDATION OF A METHODOLOGICAL FRAMEWORK BASED ON MULTI-CRITERIA DECISION ANALYSIS (MCDA) FOR ORPHAN DRUGS.
Gilabert-Perramon A; Torrent-Farnell J; Catalan A; Prat A; Fontanet M; Puig-Peiró R; Merino-Montero S; Khoury H; Goetghebeur MM; Badia X
Int J Technol Assess Health Care; 2017 Jan; 33(1):111-120. PubMed ID: 28434413
[TBL] [Abstract][Full Text] [Related]
14. Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications.
Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
BMC Health Serv Res; 2008 Dec; 8():270. PubMed ID: 19102752
[TBL] [Abstract][Full Text] [Related]
15. Determining the value contribution of selexipag for the treatment of pulmonary arterial hypertension (PAH) in Spain using reflective multi-criteria decision analysis (MCDA).
Jiménez A; Ais A; Beaudet A; Gil A
Orphanet J Rare Dis; 2018 Dec; 13(1):220. PubMed ID: 30526673
[TBL] [Abstract][Full Text] [Related]
16. Exploring physicians and patients' perspectives for current interventions on thyroid nodules using a MCDA method.
Karrer L; Zhang S; Kühlein T; Kolominsky-Rabas PL
Cost Eff Resour Alloc; 2021 May; 19(1):26. PubMed ID: 33933057
[TBL] [Abstract][Full Text] [Related]
17. Multi-Criteria Decision Analysis (MCDA) Models in Health Technology Assessment of Orphan Drugs-a Systematic Literature Review. Next Steps in Methodology Development?
Baran-Kooiker A; Czech M; Kooiker C
Front Public Health; 2018; 6():287. PubMed ID: 30374435
[No Abstract] [Full Text] [Related]
18. Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework.
Angelis A; Kanavos P
Soc Sci Med; 2017 Sep; 188():137-156. PubMed ID: 28772164
[TBL] [Abstract][Full Text] [Related]
19. Development of a Framework Based on Reflective MCDA to Support Patient-Clinician Shared Decision-Making: The Case of the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the United States.
Wagner M; Samaha D; Khoury H; O'Neil WM; Lavoie L; Bennetts L; Badgley D; Gabriel S; Berthon A; Dolan J; Kulke MH; Goetghebeur M
Adv Ther; 2018 Jan; 35(1):81-99. PubMed ID: 29270780
[TBL] [Abstract][Full Text] [Related]
20. Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward.
Baltussen R; Marsh K; Thokala P; Diaby V; Castro H; Cleemput I; Garau M; Iskrov G; Olyaeemanesh A; Mirelman A; Mobinizadeh M; Morton A; Tringali M; van Til J; Valentim J; Wagner M; Youngkong S; Zah V; Toll A; Jansen M; Bijlmakers L; Oortwijn W; Broekhuizen H
Value Health; 2019 Nov; 22(11):1283-1288. PubMed ID: 31708065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
